Susquehanna International Group, LLP Keros Therapeutics, Inc. Put Options Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
Put Options
2 transactions
Others Institutions Holding KROS
# of Institutions
172Shares Held
30.7MCall Options Held
62.4KPut Options Held
9K-
Black Rock Inc. New York, NY2.51MShares$25.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$19.9 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.52MShares$15.5 Million7.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.51MShares$15.4 Million0.01% of portfolio
-
State Street Corp Boston, MA1.11MShares$11.3 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $261M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...